All about the 1st Covid-19 vaccine registered in Russia

This group of experimental participants received the drug in a booster version — three weeks after the first vaccination, they were given the second component of the vaccine according to indications.

On August 3, a “final medical examination” of participants in clinical trials of the vaccine took place at the Burdenko Main Military Clinical Hospital, Russian Ministry of Defence said in a statement.

The results clearly showed that all volunteers had a clear immune response resulting from vaccination, the ministry said, adding that there were no side effects or abnormalities in the work of the volunteers.

According to the registration certificate, the vaccine is expected to go into civilian circulation on January 1 next year, Sputnik reported.

According to Russian Health Minister Mikhail Murashko, two sites — the Gamaleya Research Institute and a private company — will be used for producing the vaccine, said the report.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *